Search by Drug Name or NDC
NDC 68163-0749-08 DRx Choice maximum strength Severe 650; 20 mg/20mL; mg/20mL Details
DRx Choice maximum strength Severe 650; 20 mg/20mL; mg/20mL
DRx Choice maximum strength Severe is a ORAL SOLUTION in the HUMAN OTC DRUG category. It is labeled and distributed by RARITAN PHARMACEUTICALS. The primary component is ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE.
MedlinePlus Drug Summary
Acetaminophen is used to relieve mild to moderate pain from headaches, muscle aches, menstrual periods, colds and sore throats, toothaches, backaches, reactions to vaccinations (shots), and to reduce fever. Acetaminophen may also be used to relieve the pain of osteoarthritis (arthritis caused by the breakdown of the lining of the joints). Acetaminophen is in a class of medications called analgesics (pain relievers) and antipyretics (fever reducers). It works by changing the way the body senses pain and by cooling the body.
Related Packages: 68163-0749-08Last Updated: 04/28/2024
MedLinePlus Full Drug Details: Acetaminophen
Dextromethorphan is used to temporarily relieve cough caused by the common cold, the flu, or other conditions. Dextromethorphan will relieve a cough but will not treat the cause of the cough or speed recovery. Dextromethorphan is in a class of medications called antitussives. It works by decreasing activity in the part of the brain that causes coughing.
Related Packages: 68163-0749-08Last Updated: 04/28/2024
MedLinePlus Full Drug Details: Dextromethorphan
Product Information
| NDC | 68163-0749 |
|---|---|
| Product ID | 68163-749_a096cb76-0d1c-4ca8-854a-5199da0bc8f7 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | DRx Choice maximum strength Severe |
| Proprietary Name Suffix | Cough plus sore throat |
| Non-Proprietary Name | Acetaminophen, Dextromethorphan HBr |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | SOLUTION |
| Route | ORAL |
| Active Ingredient Strength | 650; 20 |
| Active Ingredient Units | mg/20mL; mg/20mL |
| Substance Name | ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE |
| Labeler Name | RARITAN PHARMACEUTICALS |
| Pharmaceutical Class | Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA] |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH FINAL |
| Application Number | part341 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 68163-0749-08 (68163074908)
| NDC Package Code | 68163-749-08 |
|---|---|
| Billing NDC | 68163074908 |
| Package | 1 BOTTLE in 1 CARTON (68163-749-08) / 237 mL in 1 BOTTLE |
| Marketing Start Date | 2023-04-24 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |